Dual Targeting of VEGFR2 and C‑Met Kinases via the Design and Synthesis of Substituted 3‑(Triazolo-thiadiazin-3-yl)indolin-2-one Derivatives as Angiogenesis Inhibitors

• Samy Mohamady,
• Mahmoud Galal,
• Wagdy M. Eldehna,
• David C. Gutierrez,
• Hany S. Ibrahim,
• Mohey M. Elmazar,
• Hamed I. Ali

Affiliations

Samy Mohamady

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt (BUE), El Sherouk City, Cairo, Egypt

Mahmoud Galal

Department of Pharmacology, Faculty of Pharmacy, Helwan University, Helwan, Cairo, Egypt

Wagdy M. Eldehna

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt

David C. Gutierrez

Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Health Science Center, Texas A&M University, Kingsville, Kingsville, Texas, United States

Hany S. Ibrahim

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo, Egypt

Mohey M. Elmazar

Department of Pharmacology and Biochemistry, Faculty of Pharmacy, The British University in Egypt (BUE), El Sherouk City, Cairo, Egypt

Hamed I. Ali

Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Health Science Center, Texas A&M University, Kingsville, Kingsville, Texas, United States